RT Journal Article
SR Electronic
T1 A Computational Growth Framework for Biological Tissues: Application to Growth of Aortic Root Aneurysm Repaired by the V-shape Surgery
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.30.21264318
DO 10.1101/2021.09.30.21264318
A1 Dong, Hai
A1 Liu, Minliang
A1 Qin, Tongran
A1 Liang, Liang
A1 Ziganshin, Bulat
A1 Ellauzi, Hesham
A1 Zafar, Mohammad
A1 Jang, Sophie
A1 Elefteriades, John
A1 Sun, Wei
A1 Gleason, Rudolph L.
YR 2021
UL http://medrxiv.org/content/early/2021/10/01/2021.09.30.21264318.abstract
AB Ascending aortic aneurysms (AsAA) often include the dilatation of sinotubular junction (STJ) which usually leads to aortic insufficiency. The novel surgery of the V-shape resection of the noncoronary sinus, for treatment of AsAA with root ectasia, has been shown to be a simpler procedure compared to traditional surgeries. Our previous study showed that the repaired aortic root aneurysms grew after the surgery. In this study, we developed a novel computational growth framework to model the growth of the aortic root repaired by the V-shape surgery. Specifically, the unified-fiber-distribution (UFD) model was applied to describe the hyperelastic deformation of the aortic tissue. A novel kinematic growth evolution law was proposed based on existing observations that the growth rate is linearly dependent on the wall stress. Moreover, we also obtained patient-specific geometries of the repaired aortic root post-surgery at two follow-up time points (Post1 and Post2) for 5 patients, based on clinical CT images. The novel computational growth framework was implemented into the Abaqus UMAT user subroutine and applied to model the growth of the aortic root from Post1 to Post2. Patient-specific growth parameters were obtained by an optimization procedure. The predicted geometry and stress of the aortic root at Post2 agree well with the in vivo results. The novel computational growth framework and the optimized growth parameters could be applied to predict the growth of repaired aortic root aneurysms for new patients and to optimize repair strategies for AsAA.Competing Interest StatementDr. Wei Sun is a co-founder and serves as the Chief Scientific Advisor of Dura Biotech. He has received compensation and owns equity in the company. Dr. Elefteriades is Principal of CoolSpine serves on the Data and Safety Monitoring Board of Vascutek, and is a consultant for CryoLife.Funding StatementThis study is in part supported by American Heart Association (AHA) 18TPA34230083Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approvals were obtained from Georgia Tech Institutional Review Board (#H20373, 10/13/2020) and Yale University Human Investigation Committee (#0109012617, 06/29/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data have been presented in the manuscript